Fortress Biotech, Inc. Public Float
Fortress Biotech, Inc. (FBIO) had Public Float of $43.74 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $43.74M.
- 2024-06-30: Entity Public Float $30.78M.
- 2023-06-30: Entity Public Float $52.87M.
- 2022-06-30: Entity Public Float $66.38M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $43.74M 10-K · filed 2026-03-31 |
| 2024-06-30 | $30.78M 10-K · filed 2025-03-31 |
| 2023-06-30 | $52.87M 10-K · filed 2024-03-28 |
| 2022-06-30 | $66.38M 10-K · filed 2023-03-31 |
| 2021-06-30 | $254.22M 10-K · filed 2022-03-28 |
| 2020-06-30 | $173.88M 10-K/A · filed 2021-04-09 |
| 2019-06-30 | $71.37M 10-K · filed 2020-03-16 |
| 2018-06-30 | $94.12M 10-K · filed 2019-03-18 |
| 2017-06-30 | $144.51M 10-K · filed 2018-03-16 |
| 2016-06-30 | $78.43M 10-K · filed 2017-03-16 |
| 2015-06-30 | $98.63M 10-K · filed 2016-03-15 |
| 2014-06-30 | $76.22M 10-K · filed 2015-03-16 |
| 2013-06-30 | $162.04M 10-K · filed 2014-03-14 |
| 2012-06-30 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |